Form 8-K - Current report:
SEC Accession No. 0000950170-24-062387
Filing Date
2024-05-20
Accepted
2024-05-20 16:08:07
Documents
58
Period of Report
2024-05-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lrmr-20240520.htm   iXBRL 8-K 41933
2 EX-99.1 lrmr-ex99_1.htm EX-99.1 21217
3 EX-99.2 lrmr-ex99_2.htm EX-99.2 45972
4 GRAPHIC img46574298_0.jpg GRAPHIC 282533
5 GRAPHIC lrmr-ex99_2s1.jpg GRAPHIC 209817
6 GRAPHIC lrmr-ex99_2s2.jpg GRAPHIC 723756
7 GRAPHIC lrmr-ex99_2s3.jpg GRAPHIC 536551
8 GRAPHIC lrmr-ex99_2s4.jpg GRAPHIC 446014
9 GRAPHIC lrmr-ex99_2s5.jpg GRAPHIC 421334
10 GRAPHIC lrmr-ex99_2s6.jpg GRAPHIC 369279
11 GRAPHIC lrmr-ex99_2s7.jpg GRAPHIC 394194
12 GRAPHIC lrmr-ex99_2s8.jpg GRAPHIC 395286
13 GRAPHIC lrmr-ex99_2s9.jpg GRAPHIC 377801
14 GRAPHIC lrmr-ex99_2s10.jpg GRAPHIC 373347
15 GRAPHIC lrmr-ex99_2s11.jpg GRAPHIC 372243
16 GRAPHIC lrmr-ex99_2s12.jpg GRAPHIC 375126
17 GRAPHIC lrmr-ex99_2s13.jpg GRAPHIC 451714
18 GRAPHIC lrmr-ex99_2s14.jpg GRAPHIC 417819
19 GRAPHIC lrmr-ex99_2s15.jpg GRAPHIC 198973
20 GRAPHIC lrmr-ex99_2s16.jpg GRAPHIC 370268
21 GRAPHIC lrmr-ex99_2s17.jpg GRAPHIC 405878
22 GRAPHIC lrmr-ex99_2s18.jpg GRAPHIC 380271
23 GRAPHIC lrmr-ex99_2s19.jpg GRAPHIC 365308
24 GRAPHIC lrmr-ex99_2s20.jpg GRAPHIC 383553
25 GRAPHIC lrmr-ex99_2s21.jpg GRAPHIC 536679
26 GRAPHIC lrmr-ex99_2s22.jpg GRAPHIC 213993
27 GRAPHIC lrmr-ex99_2s23.jpg GRAPHIC 201536
28 GRAPHIC lrmr-ex99_2s24.jpg GRAPHIC 389803
29 GRAPHIC lrmr-ex99_2s25.jpg GRAPHIC 291185
30 GRAPHIC lrmr-ex99_2s26.jpg GRAPHIC 158591
31 GRAPHIC lrmr-ex99_2s27.jpg GRAPHIC 446139
32 GRAPHIC lrmr-ex99_2s28.jpg GRAPHIC 346042
33 GRAPHIC lrmr-ex99_2s29.jpg GRAPHIC 310128
34 GRAPHIC lrmr-ex99_2s30.jpg GRAPHIC 437707
35 GRAPHIC lrmr-ex99_2s31.jpg GRAPHIC 377590
36 GRAPHIC lrmr-ex99_2s32.jpg GRAPHIC 354131
37 GRAPHIC lrmr-ex99_2s33.jpg GRAPHIC 141927
38 GRAPHIC lrmr-ex99_2s34.jpg GRAPHIC 390428
39 GRAPHIC lrmr-ex99_2s35.jpg GRAPHIC 438249
40 GRAPHIC lrmr-ex99_2s36.jpg GRAPHIC 345535
41 GRAPHIC lrmr-ex99_2s37.jpg GRAPHIC 349925
42 GRAPHIC lrmr-ex99_2s38.jpg GRAPHIC 355241
43 GRAPHIC lrmr-ex99_2s39.jpg GRAPHIC 241844
44 GRAPHIC lrmr-ex99_2s40.jpg GRAPHIC 163531
45 GRAPHIC lrmr-ex99_2s41.jpg GRAPHIC 289705
46 GRAPHIC lrmr-ex99_2s42.jpg GRAPHIC 348042
47 GRAPHIC lrmr-ex99_2s43.jpg GRAPHIC 148488
48 GRAPHIC lrmr-ex99_2s44.jpg GRAPHIC 420244
  Complete submission text file 0000950170-24-062387.txt   22177600

Data Files

Seq Description Document Type Size
49 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lrmr-20240520.xsd EX-101.SCH 23892
61 EXTRACTED XBRL INSTANCE DOCUMENT lrmr-20240520_htm.xml XML 4533
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 24964482
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)